Analytical Data
-
Gene name
C19orf62
- Application
-
Alternative Names
BABA1_HUMAN; babam1; BRCA1 A complex subunit MERIT40; BRISC and BRCA1-A complex member 1; C19orf62; FLJ20571; HSPC142; hypothetical Protein LOC29086
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NWV8
-
Expression Region
1-329aa
-
AA Sequence
MEVAEPSSPT EEEEEEEEHS AEPRPRTRSN PEGAEDRAVG AQASVGSRSE GEGEAASADD GSLNTSGAGP KSWQVPPPAP EVQIRTPRVN CPEKVIICLD LSEEMSLPKL ESFNGSKTNA LNVSQKMIEM FVRTKHKIDK SHEFALVVVN DDTAWLSGLT SDPRELCSCL YDLETASCST FNLEGLFSLI QQKTELPVTE NVQTIPPPYV VRTILVYSRP PCQPQFSLTE PMKKMFQCPY FFFDVVYIHN GTEEKEEEMS WKDMFAFMGS LDTKGTSYKY EVALAGPALE LHNCMAKLLA HPLQRPCQSH ASYSLLEEED EAIEVEATV
-
Molecular Weight
63 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C19orf62, known as Chromosome 19 Open Reading Frame 62, is a gene that has garnered attention due to its association with various cellular processes and potential implications in human diseases. Emerging research indicates that C19orf62 may play a critical role in regulating cellular stress responses, apoptosis, and cell proliferation. Its expression patterns have been linked to certain cancers and neurodegenerative disorders, suggesting that it could serve as a biomarker or therapeutic target. Given the lack of extensive characterization of the C19orf62 protein, researchers are increasingly focused on the production and study of its recombinant form to elucidate its biological functions and interactions. By utilizing recombinant DNA technology, scientists aim to generate C19orf62 protein for in vitro studies, enabling the exploration of its structural properties, functionality, and potential mechanisms of action. Understanding the role of C19orf62 in cellular processes may not only shed light on disease pathology but could also pave the way for novel therapeutic strategies. Therefore, the study of C19orf62 recombinant protein is an essential step towards unraveling its significance in health and disease, providing insights that could ultimately contribute to improved diagnostic and treatment approaches.
